In Pakistan, every 1 out of 3 Adults suffer from Hypertension. Patients at the age of 40 afflicted with hypertension have become increasingly vulnerable to a wide range of diseases. 24 hour blood pressure control is vital to prevent hypertension complications.
To meet this goal, CCL has proudly launched VALAM-H, a novel tripe combination of Valsartan, Amlodipine, & Hydrochlorothiazide, approved by FDA for the indication of lowering blood pressure. A single pill combination with the power of 3 to maintain blood pressure levels.
